Literature DB >> 35344853

Neurodegenerative model of schizophrenia: Growing evidence to support a revisit.

William S Stone1, Michael R Phillips2, Lawrence H Yang3, Lawrence S Kegeles4, Ezra S Susser5, Jeffrey A Lieberman6.   

Abstract

Multidimensional progressive declines in the absence of standard biomarkers for neurodegeneration are observed commonly in the development of schizophrenia, and are accepted as consistent with neurodevelopmental etiological hypotheses to explain the origins of the disorder. Far less accepted is the possibility that neurodegenerative processes are involved as well, or even that key dimensions of function, such as cognition and aspects of biological integrity, such as white matter function, decline in chronic schizophrenia beyond levels associated with normal aging. We propose that recent research germane to these issues warrants a current look at the question of neurodegeneration. We propose the view that a neurodegenerative hypothesis provides a better explanation of some features of chronic schizophrenia, including accelerated aging, than is provided by neurodevelopmental hypotheses. Moreover, we suggest that neurodevelopmental influences in early life, including those that may extend to later life, do not preclude the development of neurodegenerative processes in later life, including some declines in cognitive and biological integrity. We evaluate these views by integrating recent findings in representative domains such as cognition and white and gray matter integrity with results from studies on accelerated aging, together with functional implications of neurodegeneration for our understanding of chronic schizophrenia.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accelerated aging; Chronic schizophrenia; Cognition; Neurodegenerative processes; Neurodevelopmental hypothesis; White matter

Mesh:

Year:  2022        PMID: 35344853      PMCID: PMC9189010          DOI: 10.1016/j.schres.2022.03.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.662


  125 in total

Review 1.  Epidemiology and natural history of schizophrenia.

Authors:  E J Bromet; S Fennig
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

2.  Accelerated changes in white matter microstructure during aging: a longitudinal diffusion tensor imaging study.

Authors:  Claire E Sexton; Kristine B Walhovd; Andreas B Storsve; Christian K Tamnes; Lars T Westlye; Heidi Johansen-Berg; Anders M Fjell
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

Authors:  L E DeLisi; M Sakuma; W Tew; M Kushner; A L Hoff; R Grimson
Journal:  Psychiatry Res       Date:  1997-07-04       Impact factor: 3.222

4.  Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia.

Authors:  Robin Emsley; Isaac Nuamah; David Hough; Srihari Gopal
Journal:  Schizophr Res       Date:  2012-03-23       Impact factor: 4.939

Review 5.  What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia?

Authors:  Philip D Harvey
Journal:  J Clin Psychiatry       Date:  2014       Impact factor: 4.384

6.  SuperAgers in low-education setting: how to assess cognition.

Authors:  Juliana Emy Yokomizo
Journal:  Int Psychogeriatr       Date:  2020-02       Impact factor: 3.878

7.  Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.

Authors:  S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

8.  Long-term Risk of Dementia in Persons With Schizophrenia: A Danish Population-Based Cohort Study.

Authors:  Anette Riisgaard Ribe; Thomas Munk Laursen; Morten Charles; Wayne Katon; Morten Fenger-Grøn; Dimitry Davydow; Lydia Chwastiak; Joseph M Cerimele; Mogens Vestergaard
Journal:  JAMA Psychiatry       Date:  2015-11       Impact factor: 21.596

Review 9.  Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.

Authors:  Robert B Zipursky; Natasja M Menezes; David L Streiner
Journal:  Schizophr Res       Date:  2013-08-21       Impact factor: 4.939

10.  White Matter Measures and Cognition in Schizophrenia.

Authors:  Cemre Erkol; Talia Cohen; Virginie-Anne Chouinard; Kathryn Eve Lewandowski; Fei Du; Dost Öngür
Journal:  Front Psychiatry       Date:  2020-07-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.